CL2016001553A1 - Medios para cultivo celular - Google Patents
Medios para cultivo celularInfo
- Publication number
- CL2016001553A1 CL2016001553A1 CL2016001553A CL2016001553A CL2016001553A1 CL 2016001553 A1 CL2016001553 A1 CL 2016001553A1 CL 2016001553 A CL2016001553 A CL 2016001553A CL 2016001553 A CL2016001553 A CL 2016001553A CL 2016001553 A1 CL2016001553 A1 CL 2016001553A1
- Authority
- CL
- Chile
- Prior art keywords
- media
- cell culture
- phosphatidylcholine
- cholesterol
- concentration
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/35—Polyols, e.g. glycerin, inositol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/46—Amines, e.g. putrescine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/50—Soluble polymers, e.g. polyethyleneglycol [PEG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
- C12N2500/62—DMSO
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/32—Polylysine, polyornithine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Medio para usar con células CARACTERIZADO porque comprende una mezcla líquida de tampón fisiológico básico y liposomas que comprenden colesterol, fosfatidilcolina y ácidos grasos, en donde la composición formadora del liposoma comprende colesterol en una concentración que va desde 1 a 20 mg/L y la concentración final de fosfatidilcolina va de 100 a 1000 mg/L; especificaciones del mismo y el método de cultivo o criopreservación que lo usa.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361918833P | 2013-12-20 | 2013-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2016001553A1 true CL2016001553A1 (es) | 2017-03-17 |
Family
ID=53399356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2016001553A CL2016001553A1 (es) | 2013-12-20 | 2016-06-16 | Medios para cultivo celular |
Country Status (16)
Country | Link |
---|---|
US (2) | US9637721B2 (es) |
EP (1) | EP3083978A4 (es) |
JP (1) | JP2017500893A (es) |
KR (1) | KR20160125352A (es) |
CN (1) | CN106062205A (es) |
AR (1) | AR098875A1 (es) |
AU (1) | AU2014364368A1 (es) |
BR (1) | BR112016014488A2 (es) |
CA (1) | CA2934487A1 (es) |
CL (1) | CL2016001553A1 (es) |
EA (1) | EA201691297A1 (es) |
IL (1) | IL246262A0 (es) |
MX (1) | MX2016008251A (es) |
SG (1) | SG11201604994UA (es) |
TW (1) | TW201527534A (es) |
WO (1) | WO2015095651A1 (es) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015138832A1 (en) | 2014-03-13 | 2015-09-17 | The General Hospital Corporation | Devices and methods to improve and assess viability of human livers |
KR20170115514A (ko) | 2014-12-30 | 2017-10-17 | 셀 큐어 뉴로사이언시스 리미티드 | Rpe 세포 집단 및 이를 생성하는 방법 |
EP3362076A4 (en) | 2015-10-15 | 2019-03-27 | Wake Forest University Health Sciences | METHODS FOR PRODUCING IN VITRO LIVER CONSTRUCTS AND USES THEREOF |
KR20180068994A (ko) | 2015-10-16 | 2018-06-22 | 웨이크 포리스트 유니버시티 헬스 사이언시즈 | 다층 기도 오가노이드 및 그의 제조 및 사용 방법 |
US20180369336A1 (en) * | 2015-12-03 | 2018-12-27 | Boston Medical Center Corporation | B cell-based cancer immunotherapy |
CN105567628B (zh) * | 2016-01-30 | 2019-07-12 | 令世鑫 | 一种全悬浮培养mdck细胞的低血清培养基 |
CN105695407B (zh) * | 2016-03-15 | 2019-04-16 | 佰通生物技术(苏州)有限公司 | 一种对干细胞具有活化作用的微量元素组合物及其应用 |
EP3430127A4 (en) * | 2016-03-18 | 2019-09-04 | Institute of Biophysics Chinese Academy of Sciences | CELL CULTURE MEDIA AND CULTURE MEDIUM SUPPLEMENT |
TWI734775B (zh) * | 2016-04-26 | 2021-08-01 | 美商美國泰福生技股份有限公司 | 細胞培養基 |
CN106119186B (zh) * | 2016-06-24 | 2019-10-08 | 肇庆大华农生物药品有限公司 | 一种用于全悬浮培养mdck细胞的无血清培养基及其制备方法 |
CN106497872B (zh) * | 2016-12-01 | 2019-10-11 | 北京欣博睿丰医疗科技发展有限公司 | 骨骼肌干细胞无血清培养基及其制备方法和应用 |
TW201831675A (zh) * | 2017-02-01 | 2018-09-01 | 美商歐瑞3恩公司 | 基於細胞之基因特質用於定制用於最佳化細胞增殖的細胞培養基之系統及方法 |
WO2018181342A1 (ja) * | 2017-03-28 | 2018-10-04 | 味の素株式会社 | 未分化維持培地添加剤 |
CN107177542A (zh) * | 2017-05-25 | 2017-09-19 | 句容亿格纳米材料厂 | 一种促进培养基中谷氨酰胺溶解的优化方法 |
PL3436568T3 (pl) * | 2017-05-31 | 2023-11-20 | Promocell Gmbh | Podłoże hodowlane do pluripotencjalnych komórek macierzystych |
US20200154697A1 (en) * | 2017-06-14 | 2020-05-21 | The General Hospital Corporation | High subzero cryopreservation |
CN107488625B (zh) * | 2017-08-31 | 2018-12-21 | 广州蕊特生物科技有限公司 | 一种胎牛血清替代物及其制备方法和应用 |
CN109395095B (zh) * | 2017-09-18 | 2021-09-24 | 武汉原生原代生物医药科技有限公司 | 体内用生物膜及其制备方法和用途 |
EP3694517A4 (en) * | 2017-10-11 | 2021-07-14 | Bast Biotechnology | COMPOSITIONS AND METHODS OF TREATMENT OF FIBROSIS |
CA3078759A1 (en) * | 2017-10-13 | 2019-04-18 | Boehringer Ingelheim International Gmbh | Perfusion medium |
WO2019081609A1 (en) * | 2017-10-24 | 2019-05-02 | Fundación Instituto De Investigación Sanitaria De Santiago De Compostela (Fidis) | NANOSYSTEMS FOR CELL PROLIFERATION |
KR102569522B1 (ko) * | 2017-11-24 | 2023-08-24 | 주식회사 차바이오랩 | 세포 동결 보존용 조성물 및 이를 이용한 세포 동결 보존 방법 |
JP7498664B2 (ja) * | 2017-12-29 | 2024-06-12 | セル キュア ニューロサイエンシズ リミテッド | 網膜色素上皮細胞組成物 |
CN108853489B (zh) * | 2018-06-29 | 2019-07-02 | 陕西诺威利华生物科技有限公司 | 一种利用无血清培养基生产pedv弱毒疫苗的方法 |
CN108815516B (zh) * | 2018-06-29 | 2019-03-15 | 陕西诺威利华生物科技有限公司 | 一种利用无血清培养基生产pedv灭活疫苗的方法 |
CN109234223B (zh) * | 2018-11-21 | 2021-01-19 | 南京基蛋生物医药有限公司 | 低蛋白无血清细胞培养基 |
KR102271949B1 (ko) * | 2019-04-15 | 2021-07-02 | 순천향대학교 산학협력단 | 포스파티딜콜린을 함유하는 선충 배양용 조성물 및 이를 이용한 선충의 배양방법 |
WO2020218584A1 (ja) * | 2019-04-26 | 2020-10-29 | 味の素株式会社 | 細胞培養用組成物 |
KR102132457B1 (ko) * | 2019-05-10 | 2020-07-09 | 주식회사 바이오솔루션 | 세포외 소포를 고농도로 배양하기 위한 세포 배양배지 및 상기 세포 배양배지를 이용한 세포외 소포 고 함유 조건화 배양액의 제조방법 |
CN109943526B (zh) * | 2019-05-23 | 2019-09-13 | 广州赛莱拉干细胞科技股份有限公司 | 一种促间充质干细胞增殖的无血清多肽组合物 |
WO2021078935A1 (en) * | 2019-10-25 | 2021-04-29 | Fundació Centre De Regulació Genòmica | Culture media for mycoplasma |
WO2021108806A1 (en) * | 2019-11-29 | 2021-06-03 | Rutgers, The State University Of New Jersey | Compositions, kits and methods for storage of blood products and methods of use thereof |
JP7492013B2 (ja) * | 2020-01-21 | 2024-05-28 | イッサム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッド | 培養培地中でのfgf活性化剤の利用 |
CN111849860B (zh) * | 2020-06-01 | 2021-12-21 | 浙江大学 | 一种利用铁元素调控肠道干细胞分化的方法及应用 |
CN111534478A (zh) * | 2020-06-24 | 2020-08-14 | 肇庆大华农生物药品有限公司 | 用于培养mdck细胞系的培养基及其制备方法 |
CN112514892B (zh) * | 2020-12-25 | 2022-06-14 | 广州赛莱拉干细胞科技股份有限公司 | 一种外泌体冻存保护液及其制备方法 |
CN112501113B (zh) * | 2021-02-03 | 2021-04-27 | 上海奥浦迈生物科技股份有限公司 | 一种hek293细胞组合梯度培养基及其用途 |
CN113061584A (zh) * | 2021-05-14 | 2021-07-02 | 赵峻岭 | 一种能促进腺病毒生长的培养基添加物 |
US11878036B2 (en) | 2022-05-25 | 2024-01-23 | Neuvian LLC | Vaginal care compositions and methods of improving vaginal health |
WO2024024892A1 (ja) * | 2022-07-28 | 2024-02-01 | 公立大学法人山陽小野田市立山口東京理科大学 | 凍結保存用の組成物、凍結保存方法、及び凍結した細胞又は生体組織 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4721676A (en) * | 1982-12-14 | 1988-01-26 | Genencor, Inc. | Novel thermophile isolate having thermostable hydrolytic activity |
US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
DE3827578A1 (de) | 1988-08-13 | 1990-02-15 | Siepmann Friedrich W | Verfahren und vorrichtung zur bestimmung oxidierbarer wasserinhaltsstoffe einer waessrigen probenfluessigkeit |
US6048728A (en) | 1988-09-23 | 2000-04-11 | Chiron Corporation | Cell culture medium for enhanced cell growth, culture longevity, and product expression |
US5834312A (en) | 1990-01-29 | 1998-11-10 | Hy-Gene, Inc. | Process and media for the growth of human epithelia |
US5952198A (en) * | 1995-05-04 | 1999-09-14 | Bayer Corporation | Production of recombinant Factor VIII in the presence of liposome-like substances of mixed composition |
WO1997006784A1 (en) | 1995-08-15 | 1997-02-27 | Universite Libre De Bruxelles | Liposomes preparation method and plant |
JP4421681B2 (ja) * | 1995-10-19 | 2010-02-24 | バイオ‐オリジン エルエルシー | 生殖細胞および胚の生存および機能を改善する方法および組成物 |
EP1482031B1 (en) | 1996-08-30 | 2015-10-28 | Life Technologies Corporation | Serum-free mammalian cell culture medium, and uses thereof |
AU4751697A (en) | 1996-10-10 | 1998-05-05 | Douglas Danner | Animal cell culture media comprising plant-derived nutrients |
US6833271B2 (en) * | 1996-12-04 | 2004-12-21 | Medi-Cult A/S | Serum-free cell culture media |
US5985538A (en) | 1997-08-01 | 1999-11-16 | Saint Barnabas Medical Center | Cryopreservation and cell culture medium comprising less than 50 mM sodium ions and greater than 100 mM choline salt |
GB9817805D0 (en) | 1998-08-14 | 1998-10-14 | Danisco | Use of a composition |
CA2852534A1 (en) | 1999-08-05 | 2001-02-15 | Abt Holding Company | Multipotent adult stem cells and methods for isolation |
US7112576B1 (en) * | 1999-12-10 | 2006-09-26 | Regents Of The University Of Minnesota | Compositions and methods for cryopreservation of peripheral blood lymphocytes |
US7455983B2 (en) | 2000-01-11 | 2008-11-25 | Geron Corporation | Medium for growing human embryonic stem cells |
BRPI0307074A2 (pt) | 2002-01-25 | 2017-06-20 | Genzyme Corp | meios sem soro para condrócitos e métodos para seu uso |
EP1475434A1 (en) * | 2003-05-09 | 2004-11-10 | Oncoscience AG | Method for storing tumor cells |
WO2005072523A2 (en) | 2004-02-02 | 2005-08-11 | I.M.T. Interface Multigrad Technology Ltd. | Biological material and methods and solutions for preservation thereof |
US8252591B2 (en) | 2004-05-07 | 2012-08-28 | Whitehead Institute For Biomedical Research | Hormone responsive tissue culture system and uses thereof |
US20050287666A1 (en) | 2004-06-29 | 2005-12-29 | Invitrogen Corporation | Cell culture medium comprising transition metals or trace elements |
AU2005271723B2 (en) | 2004-07-13 | 2010-12-16 | Asterias Biotherapeutics, Inc. | Medium for growing human embryonic stem cells |
WO2006045064A2 (en) | 2004-10-20 | 2006-04-27 | Whitehead Institute For Biomedical Research | Cultured hematopoietic stem cells and method for expansion and analysis thereof |
JP4833991B2 (ja) | 2004-11-02 | 2011-12-07 | アレス トレーディング ソシエテ アノニム | 哺乳動物細胞のための無血清細胞培養培地 |
CA2595638A1 (en) * | 2005-01-28 | 2006-08-03 | Canadian Blood Services | A method of cryopreserving cells and tissues by liposomal delivery of sugars to enhance post-thaw viability |
WO2007016366A2 (en) | 2005-07-29 | 2007-02-08 | Yale University | Defined culture conditions of human embryonic stem cells |
EP1966370B1 (en) | 2005-12-21 | 2013-02-20 | SentoClone International AB | Method for obtaining T-lymphocytes |
DK2420565T3 (en) | 2006-02-23 | 2017-12-04 | Viacyte Inc | APPLICABLE COMPOSITIONS AND METHODS FOR CULTIVATING DIFFERENTIBLE CELLS |
JP5080779B2 (ja) * | 2006-10-25 | 2012-11-21 | テルモ株式会社 | リポソーム製剤の製造方法 |
WO2008137641A2 (en) | 2007-05-04 | 2008-11-13 | Whitehead Institute For Biomedical Research | Ex vivo expansion of human hematopoietic stem cells |
US20110244502A1 (en) | 2007-08-10 | 2011-10-06 | Whitehead Institute For Biomedical Research | Hormone responsive tissue culture system and uses thereof |
FI20096288A0 (fi) * | 2009-12-04 | 2009-12-04 | Kristiina Rajala | Formulations and methods for culturing stem cells |
MX2014005723A (es) | 2011-11-11 | 2014-11-25 | Essential Pharmaceuticals Llc | Kit que comprende factores labiles y de reemplazo de suero. |
-
2014
- 2014-12-19 CN CN201480075947.7A patent/CN106062205A/zh active Pending
- 2014-12-19 US US14/577,414 patent/US9637721B2/en not_active Expired - Fee Related
- 2014-12-19 TW TW103144675A patent/TW201527534A/zh unknown
- 2014-12-19 AU AU2014364368A patent/AU2014364368A1/en not_active Abandoned
- 2014-12-19 MX MX2016008251A patent/MX2016008251A/es unknown
- 2014-12-19 CA CA2934487A patent/CA2934487A1/en not_active Abandoned
- 2014-12-19 JP JP2016560860A patent/JP2017500893A/ja active Pending
- 2014-12-19 EP EP14870754.0A patent/EP3083978A4/en not_active Withdrawn
- 2014-12-19 EA EA201691297A patent/EA201691297A1/ru unknown
- 2014-12-19 BR BR112016014488A patent/BR112016014488A2/pt not_active IP Right Cessation
- 2014-12-19 KR KR1020167019241A patent/KR20160125352A/ko not_active Application Discontinuation
- 2014-12-19 WO PCT/US2014/071388 patent/WO2015095651A1/en active Application Filing
- 2014-12-19 AR ARP140104810A patent/AR098875A1/es unknown
- 2014-12-19 SG SG11201604994UA patent/SG11201604994UA/en unknown
-
2016
- 2016-06-16 CL CL2016001553A patent/CL2016001553A1/es unknown
- 2016-06-16 IL IL246262A patent/IL246262A0/en unknown
-
2017
- 2017-03-28 US US15/471,621 patent/US20170198251A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2934487A1 (en) | 2015-06-25 |
KR20160125352A (ko) | 2016-10-31 |
JP2017500893A (ja) | 2017-01-12 |
CN106062205A (zh) | 2016-10-26 |
US9637721B2 (en) | 2017-05-02 |
BR112016014488A2 (pt) | 2017-08-08 |
WO2015095651A1 (en) | 2015-06-25 |
AR098875A1 (es) | 2016-06-22 |
EA201691297A1 (ru) | 2016-11-30 |
IL246262A0 (en) | 2016-07-31 |
US20170198251A1 (en) | 2017-07-13 |
US20150175956A1 (en) | 2015-06-25 |
EP3083978A1 (en) | 2016-10-26 |
TW201527534A (zh) | 2015-07-16 |
AU2014364368A1 (en) | 2016-07-07 |
MX2016008251A (es) | 2016-10-13 |
SG11201604994UA (en) | 2016-07-28 |
EP3083978A4 (en) | 2017-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016001553A1 (es) | Medios para cultivo celular | |
MX352823B (es) | Formulaciones de proteinas que contienen aminoacidos. | |
AR119552A2 (es) | Producción de una n-acetilgalactosamina-6-sulfatasa humana activa altamente fosforilada y sus usos | |
BR112015001620A2 (pt) | composição de meio de cultura, e método para cultivo de célula ou tecido usando-se dita composição | |
CO6630182A2 (es) | Microorganismos y métodos para la biosíntesis de butadieno | |
CO6721031A2 (es) | Composición para mejorar la recuperación de petroleo que incluye microbiosy componentes bassados en el aminoácido n-lauroilo | |
CL2012002013A1 (es) | Microorganismos aislado thrastochytrium sp. atcc pta-10212 util en la produccion de acidos grasos omega-3 | |
AR087745A1 (es) | Composiciones y metodos que comprenden una variante de enzima lipolitica | |
AR085943A1 (es) | Composicion antimicrobiana | |
CL2014003225A1 (es) | Composición que comprende un agente de control biológico y un fungicida. | |
IN2014DN07483A (es) | ||
CO2017004735A2 (es) | Moléculas que tienen utilidad plaguicida e intermediarios, composiciones y procedimientos relacionados con las mismas | |
CR20150310A (es) | Solución para preservar conductos vasculares | |
AR082943A1 (es) | Formula nutricional predigerida | |
AR087911A1 (es) | Metodos en multiples etapas y composiciones para desensibilizar las caras de formaciones subterraneas | |
AR092630A1 (es) | Metodos y composiciones para prevenir la incorporacion erronea de norleucina en proteinas | |
AR099500A1 (es) | Composición para el desmucilaginado enzimático de aceite | |
CL2012003488A1 (es) | Formulación intravenosa que comprende una solución acuosa de sulfobutil-eter-beta-ciclodextrina y amiodarona o una sal en proporción entre 2,7: 1 a 7:1; metodo de preparación; un artículo manufacturado, util en arritmias. | |
CO7240370A2 (es) | Forma farmaceútica para la liberación prolongada de sustancias activas | |
CL2012002781A1 (es) | Producto que comprende un cuerpo de alimento compuesto por un componente de alimento y un componente de infusion que contiene mal todextrina en una concentracon de 5 a 65% con respecto al cuerpo del alimento; producto alimenticio; metodo para producir un cuerpo de alimento infusionado; y formulaciones de infusion. | |
ECSP17068868A (es) | Archaebacteria en alimento para animales bioactivo, método para hacer la composición y métodos que emplean la composición | |
UY34552A (es) | Forma cristalina delta de la sal de arginina de perindoprilo, su procedimiento de preparación, y las composiciones farmacéuticas que la contienen | |
CL2014003480A1 (es) | Uso de huevos de ácaros astigmátidos como fuente de nutrientes para una población de agentes de control biológico de artrópodos; composición de control biológico que comprende los agentes de control y la fuente de nutrientes; y método para criar artrópodos. | |
AR094875A1 (es) | Formulaciones y procedimientos para la producción de proteína recombinante aumentada | |
PE20142080A1 (es) | Composiciones que contienen maltotriosa y formas de uso de la misma para inhibir el dano causado por el proceso de deshidratacion |